Assessing taxane-associated adverse events using the FDA adverse event reporting system database

Volume: 134, Issue: 12, Pages: 1471 - 1476
Published: Jun 1, 2021
Abstract
Taxanes are an essential class of antineoplastic agents used to treat various cancers and are a fundamental cause of hypersensitivity reactions. In addition, other adverse events, such as bone marrow toxicity and peripheral neuropathy, can lead to chemotherapy discontinuation. This study aimed to evaluate the safety of taxanes in the real world.Taxane-associated adverse events were identified by the Medical Dictionary for Regulatory Activities...
Paper Details
Title
Assessing taxane-associated adverse events using the FDA adverse event reporting system database
Published Date
Jun 1, 2021
Volume
134
Issue
12
Pages
1471 - 1476
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.